Kathleen S. Wright Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.63M Buy
8,700
+1,200
+16% +$206K 0.61% 35
2025
Q2
$1.22M Buy
7,500
+227
+3% +$34.9K 0.48% 42
2025
Q1
$1.15M Sell
7,273
-1,944
-21% -$304K 0.48% 39
2024
Q4
$1.33M Hold
9,217
0.56% 37
2024
Q3
$1.49M Buy
9,217
+17
+0.2% +$2.71K 0.61% 36
2024
Q2
$1.36M Hold
9,200
0.62% 36
2024
Q1
$1.41M Sell
9,200
-100
-1% -$15.9K 0.66% 36
2023
Q4
$1.48M Hold
9,300
0.75% 35
2023
Q3
$1.46M Buy
9,300
+6,300
+210% +$1.04M 0.82% 33
2023
Q2
$497K Sell
3,000
-3,700
-55% -$597K 0.32% 59
2023
Q1
$1.04M Sell
6,700
-1,620
-19% -$262K 0.68% 42
2022
Q4
$1.47M Buy
8,320
+100
+1% +$17.3K 1% 29
2022
Q3
$1.34M Buy
8,220
+20
+0.2% +$3.38K 1.09% 28
2022
Q2
$1.46M Hold
8,200
1.23% 25
2022
Q1
$1.45M Hold
8,200
1.06% 28
2021
Q4
$1.4M Buy
+8,200
New +$1.34M 1.03% 28

Other funds holding JNJ

Kathleen S. Wright Associates's JNJ Position: Q3 2025 in Review

Kathleen S. Wright Associates increased its Johnson & Johnson (JNJ) stake by 16% in Q3 2025, buying an estimated $206K and bringing the position to 8,700 shares worth $1.63M. The position accounts for 0.61% of the portfolio, ranked #35.

Kathleen S. Wright Associates first reported a position in JNJ in Q4 2021 and has held it in 16 quarters since. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Kathleen S. Wright Associates held 8,700 shares of Johnson & Johnson worth $1.63M as of Q3 2025.
  • Kathleen S. Wright Associates bought 1,200 Johnson & Johnson shares in Q3 2025, an estimated $206K.
  • Johnson & Johnson made up 0.61% of Kathleen S. Wright Associates's portfolio in Q3 2025, its #35 holding.
  • Kathleen S. Wright Associates first reported a position in Johnson & Johnson in Q4 2021 and has held it in 16 quarters since.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Kathleen S. Wright Associates's 13F filing for Q3 2025, filed 10 Oct 2025.